Voriconazole therapeutic drug monitoring among lung transplant recipients receiving targeted therapy for invasive aspergillosis-Reference-Cited by-同舟云学术

Voriconazole therapeutic drug monitoring among lung transplant recipients receiving targeted therapy for invasive aspergillosis

Author:

Butler‐Laporte Guillaume¹,Langevin Marie‐Claude²,Lemieux Claude³,Poirier Charles⁴,Ferraro Pasquale⁵,Théorêt Yves⁶,Luong Me‐Linh³^ORCID

Affiliation:

1. Department of Epidemiology, Biostatistics, and Occupational Health McGill University Montréal Canada

2. Department of Pharmacy Centre Hospitalier de l'Université de Montréal Montréal Canada

3. Department of Medical Microbiology Centre de Recherche du Centre Hospitalier de l'Université de Montréal Montréal Canada

4. Division of Respirology, Department of Medicine Centre de Recherche du Centre Hospitalier de l'Université de Montréal Montréal Canada

5. Division of Thoracic Surgery, Department of Surgery Centre de Recherche du Centre Hospitalier de l'Université de Montréal Montréal Canada

6. Department of Pharmacology Centre de Recherche Pédiatrique, Hôpital Ste‐Justine Montréal Canada

Publisher

Wiley

Subject

Transplantation

Link

Reference23 articles.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Voriconazole;Reactions Weekly;2022-10-08